SÃO PAULO, BRAZIL — Hospitalar, South America’s most influential healthcare industry event, wrapped up another highly successful edition at the São Paulo Convention Center. As a premier platform for global medical innovation, this year’s exhibition spanned over 100,000 square meters, bringing together 1,272 international exhibitors and drawing more than 85,000 healthcare professionals and industry leaders.

Making an impactful debut at the event, Concemed showcased its core portfolio, including the flagship V1000 Video Endoscopy System and optical magnifying endoscopes. The booth became a major point of interest, earning high praise from clinical experts, distribution partners, and industry pioneers from across the globe.

   Exhibition Highlights: Driving Innovation in Early Cancer Screening

The centerpiece of the Concemed showcase was our cutting-edge video endoscopy system and optical magnification endoscopes. The technical sophistication of these platforms drew dense crowds to the booth, with visitors highlighting several breakthrough capabilities:

  New vision of Imaging: 145x optical magnification combined with an unique One-click Autofocus mechanism, allowing clinicians to visualize micro-structures and micro-vascular with extreme clarity.

   Superior Signal Fidelity: Advanced multi-laser transmission technology ensuring unmatched image stability and high-definition signal integrity.

  Targeted Diagnostics: Combining multi-spectral imaging technology with magnifying endoscope engineered to enhance lesion boundary identification and improve early-stage cancer detection rates.

   Physician-Centric Ergonomics: An enhanced handgrip design and advanced colon insertion technique that delivers exceptional tactile responsiveness and maneuverability.

   On-Site Success: Resounding Acclaim from LATAM Clinicians

Throughout the four-day event, the Concemed booth was a vibrant hub for endoscopy center directors, gastroenterologists, and tier-one distributors from across Latin America—including Brazil, Argentina, Peru, Colombia, Venezuela, the Dominican Republic, and Ecuador.

  A Veteran Surgeon’s Perspective: A Brazilian surgeon with 20 years of clinical experience praised the system's intuitive handling and the pixel-perfect quality of the magnified view, expressing an eager desire to integrate the system into their operating room as soon as possible.

  Shifting Market Preferences: Multiple medical professionals from São Paulo—long accustomed to traditional premium international brands—noted after trialing the V1000 that its potential for boosting accuracy in early-stage cancer screenings makes it a highly anticipated alternative for the local market.

  Commercial Momentum: Impressed by the robust capabilities and the steady progress of our local regulatory approvals, several leading Latin American medical distributors proactively established contact to secure strategic partnerships ahead of the commercial rollout.

  Conclusion

Hospitalar 2026 has significantly amplified Concemed’s brand footprint and laid a rock-solid foundation for our long-term growth across South America. Guided firmly by real-world clinical needs, we will continue to advance the global adoption of innovative technologies like our magnifying endoscopes—bringing the life-saving benefits of precise, early-stage cancer diagnosis to patients worldwide.